Aventis Ketek Approved By FDA; Antibiotic Launch Planned For Late July
This article was originally published in The Pink Sheet Daily
Executive Summary
Telithromycin is approved for the treatment of acute exacerbation of chronic bronchitis, acute bacterial sinusitis, and mild-to-moderate community acquired pneumonia. Phase IV commitments include pediatric studies in CAP and sinusitis.